Mitochondrial determinants of monocyte dysfunction in aging

衰老过程中单核细胞功能障碍的线粒体决定因素

基本信息

  • 批准号:
    10514864
  • 负责人:
  • 金额:
    $ 41.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Aging is the primary risk factor for nearly all chronic diseases, and additionally is associated with increased severity of a number of acute infectious diseases. These phenomena are linked by dysregulation of the innate immune system, which contributes both to immune dysfunction (immunosenescence) and chronic low-grade inflammation (inflammaging). Monocytes are key innate immune cells that circulate and release pro-inflammatory cytokines to contribute to inflammaging, but also have suppressed inflammatory responses upon infectious or inflammatory challenge in older individuals. Aged monocytes also have aberrant mitochondrial function, but this observation has not been linked to inflammatory dysfunction, despite the well-known association between cellular metabolism and immune function. In this application, we propose in Aim 1 to investigate a metabolic mechanism linking dysfunction of mitochondrial complex I to impaired inflammatory responses in monocytes from older adults. Additionally, we propose in Aim 2 to utilize a novel mitochondrial transplant procedure to rescue metabolic function in aging, thereby reversing cellular dysfunction in aged monocytes. We will utilize human and mouse experiments to investigate these hypotheses. Results from this study will establish a myeloid cell metabolic pathway which mediates immune dysfunction in monocytes during aging. Delineation of this pathway could provide new therapeutic targets for treating conditions associated with inflammaging and/or immunosenescence. As aging is a primary risk factor for many chronic and infectious diseases, this could have wide-ranging implications. Additionally, we will conduct preclinical testing of a simple and relatively inexpensive therapy which is cell-type specific and known to be efficacious in regularizing inflammatory function in myeloid cells in other systems. Results from this study will enhance our understanding of innate immune dysfunction during aging, leading to new treatments for associated diseases.
衰老是几乎所有慢性疾病的主要危险因素,并且还与 一些急性传染病的严重程度。这些现象与先天失调有关 免疫系统,导致免疫功能障碍(免疫衰老)和慢性低度恶性 炎症(发炎)。单核细胞是循环和释放促炎物质的关键先天免疫细胞 细胞因子促进炎症,但也抑制感染或感染时的炎症反应 老年人的炎症挑战。衰老的单核细胞也有异常的线粒体功能,但这 观察结果尚未与炎症功能障碍相关,尽管众所周知 细胞代谢和免疫功能。 在此应用中,我们在目标 1 中建议研究与线粒体功能障碍相关的代谢机制。 复合物 I 对老年人单核细胞炎症反应受损的影响。此外,我们在 Aim 中提出 2 利用新型线粒体移植手术来挽救衰老过程中的代谢功能,从而逆转 老化单核细胞的细胞功能障碍。我们将利用人类和小鼠实验来研究这些 假设。 这项研究的结果将建立一个介导免疫功能障碍的骨髓细胞代谢途径 衰老过程中的单核细胞。这条途径的描述可以为治疗疾病提供新的治疗靶点 与炎症和/或免疫衰老有关。由于衰老是许多慢性病和慢性病的主要危险因素 传染病,这可能会产生广泛的影响。此外,我们还将进行临床前测试 一种简单且相对便宜的疗法,具有细胞类型特异性,并且已知可有效调节细胞类型 其他系统中骨髓细胞的炎症功能。这项研究的结果将增强我们的理解 衰老过程中先天免疫功能障碍的研究,导致相关疾病的新治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brandt D. Pence其他文献

Dietary (1,3/1,6)-<em>β</em>-<span class="small-caps">d</span>-glucan decreases transforming growth factor <em>β</em> expression in the lung of the neonatal piglet
  • DOI:
    10.1016/j.nutres.2013.02.006
  • 发表时间:
    2013-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shannon C. Thorum;Shelly N. Hester;Sarah S. Comstock;Marcia H. Monaco;Brandt D. Pence;Jeffrey A. Woods;Sharon M. Donovan
  • 通讯作者:
    Sharon M. Donovan

Brandt D. Pence的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
  • 批准号:
    10712647
  • 财政年份:
    2001
  • 资助金额:
    $ 41.41万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    6247642
  • 财政年份:
    1997
  • 资助金额:
    $ 41.41万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    3718999
  • 财政年份:
  • 资助金额:
    $ 41.41万
  • 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
  • 批准号:
    465668867
  • 财政年份:
  • 资助金额:
    $ 41.41万
  • 项目类别:
    Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
  • 批准号:
    3719026
  • 财政年份:
  • 资助金额:
    $ 41.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了